LLY Jan 2024 450.000 put
| Previous close | 5.0200 |
| Open | 4.6300 |
| Bid | 4.5500 |
| Ask | 4.8500 |
| Strike | 450.00 |
| Expiry date | 2024-01-19 |
| Day's range | 4.2000 - 4.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | 752 |
Motley Fool3 Magnificent Growth Stocks to Buy Right Now
Three Fool.com contributors believe they've identified truly magnificent growth stocks to buy right now. Here's why they chose AstraZeneca (NASDAQ: AZN), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (AstraZeneca): What makes AstraZeneca a magnificent long-term investment is how broad the business is and the potential it has to generate long-term gains.
BloombergObesity Drug Market Set to Hit $100 Billion by 2035, BMO Says
(Bloomberg) -- The global market for novel weight-loss drugs like Novo Nordisk A/S’s Ozempic and Wegovy is poised to reach $100 billion by 2035 as patients start to understand the efficacy of the medications.Most Read from BloombergChinese Gold Buying Is Driving a Paradigm Shift in BullionStocks Flash Recession Warning as Trouble Spreads to IndustrialsWells Fargo Preps for Wealth Battle After $1 Billion TurnaroundBond Market Faces Quandary After Fed Signals It’s Almost DoneUS to Keep a Distance
Motley FoolAre Wall Street Analysts Wrong About Eli Lilly Stock?
Based on analysts' projections, you might think the pharmaceutical giant isn't worth investing in right now.
